Accelerate to Discover
Related topics
How microCT can provide insight into dynamic disease processes webinar
Jun 19, 2018
Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives...
xCELLIgence webinar: label-free real-time cell analysis technology for Immuno-Oncology
Jun 5, 2018
Cancer immunotherapies harness and enhance the innate power of the immune system to eliminate cancer cells and have...
Photoacoustic Imaging of placental oxygenation
May 16, 2018
Watch the new webinar about photoacoustick imaging presented by Dr. Liliya M. Yamaleyeva, Assistant Professor in the...
BioFlux webinar: Introducing new plates and capabilities of BioFlux microfluidic system
May 13, 2018
BioFlux biofilm assays can now be performed on the popular catheter material polydimethylsiloxane (PDMS). Silicone...
IncuCyte webinar: advanced 3D cell models providing greater biological insight
Apr 30, 2018
Cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of...
ACEA webinar series: Using xCELLigence RTCA to study biofilms formation
Feb 14, 2018
xCELLigence instruments are revolutionizing pure and applied biofilm research. Beyond gains in efficiency, the...
NovoCyte live technical webinar: a flow cytometry method for detecting bacteria in water
Feb 9, 2018
Regulatory testing for microbiological water quality is often conducted by growing microbes on agar medium in visible...
Studying bacterial biofilm formation and stress responses using the BioFlux microfluidic platform
Dec 14, 2017
Dr. Webber is a group leader at the Quadrum Institute and a leading authority on antimicrobial resistance. Recently,...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
